# 2026-08513: September Medicare Panel Meets on Lab Test Rates

2026-08513, Medicare Program; Meeting Announcement for the Public and the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests-September 2026, is a Federal Register notice from Health and Human Services Department, Centers for Medicare & Medicaid Services published 2026-05-01, effective 2026-09-15; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-08513
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08513
- Title: Medicare Program; Meeting Announcement for the Public and the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests-September 2026
- Type: Notice
- Agencies: Health and Human Services Department; Centers for Medicare & Medicaid Services
- Citation: 91 FR 23418
- Published: 2026-05-01
- Effective: 2026-09-15
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

September Medicare Panel Meets on Lab Test Rates

## Summary

Medicare is hosting a virtual meeting on September 15-16, 2026, where experts and the public will discuss how to set fair payment rates for certain lab tests. If you’re involved in clinical lab testing or Medicare payments, this is your chance to share ideas before decisions are made. Don’t miss the August 21 deadline to register or submit comments—this could impact how much Medicare pays for lab tests next year!

## Abstract

This notice announces meeting dates for a Clinical Laboratory Fee Schedule (CLFS) public meeting that includes the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests (the Panel) on Tuesday, September 15, 2026 and Wednesday, September 16, 2026. The purpose of the Panel is to advise the Secretary of the Department of Health and Human Services and the Administrator of the Centers for Medicare & Medicaid Services on issues related to clinical diagnostic laboratory tests (CDLTs). During the meeting, the public will have an opportunity to present recommendations (including data on which recommendations are based) on the appropriate basis for establishing payment amounts for CDLTs (crosswalking or gapfilling) for which CMS received no applicable information during the data reporting period from May 1, 2026 through July 31, 2026 to calculate Medicare payment rates. After the public provides this input, the Panel will provide its recommendations to the Secretary and the Administrator on payment recommendations for these CDLTs.

## Effects PRIA read

- Speak to CMS About Lab Payments: benefit, medium. If you work for a clinical laboratory or handle Medicare lab payments, you can present recommendations at a virtual meeting on September 15–16, 2026 from 10:00 a.m. to 4:00 p.m. EDT. Registration and written presentations (and requests for special accommodations) must be submitted by August 21, 202…
- List of Codes Lacking Data Posted: benefit, low. CMS will post, in early August 2026, a list of Clinical Laboratory Fee Schedule (CLFS) codes for which it received no applicable information during the May 1, 2026 through July 31, 2026 data reporting period. The list will identify the CY 2027 codes that are the subject of crosswalking or gapfillin…
- How CMS Will Set Payment for No-Data Tests: mixed, medium. For CLFS test codes where CMS received no applicable information, Medicare payment will be determined using either "crosswalking" or "gapfilling" under 42 CFR 414.507(f). CMS plans to post proposed determinations and supporting data in late September 2026, accept written comments in October 2026, a…

## Related documents

- [2026-22812](https://policyrisk.com/federal-register/2026-22812): Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care, 2026-11-10
- [2026-22750](https://policyrisk.com/federal-register/2026-22750): Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the E…, 2026-11-09
- [2026-22792](https://policyrisk.com/federal-register/2026-22792): Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, 2026-11-09
- [2026-22743](https://policyrisk.com/federal-register/2026-22743): Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage…, 2026-11-09
- [2026-22739](https://policyrisk.com/federal-register/2026-22739): Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; i…, 2026-11-06
- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03

## Sources
- [2026-08513 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/01/2026-08513/medicare-program-meeting-announcement-for-the-public-and-the-medicare-advisory-panel-on-clinical)
- [2026-08513 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-01/pdf/2026-08513.pdf)

## Related
- [Previous: 2026-08512, Medicare Program: Rechartering, Membership, and Meeting Announcement for the Me…](https://policyrisk.com/federal-register/2026-08512)
- [Next: 2026-08514, Welded Line Pipe From South Korea and Turkey; Institution of Five-Year Reviews](https://policyrisk.com/federal-register/2026-08514)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08513 (as of 2026-06-08).
